- Home
- HTB vs SAGE Comparison
HTB vs SAGE Comparison
Compare HTB & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTB
- SAGE
- Stock Information
- Founded
- HTB 1926
- SAGE 2010
- Country
- HTB United States
- SAGE United States
- Employees
- HTB N/A
- SAGE N/A
- Industry
- HTB
- SAGE Biotechnology: Pharmaceutical Preparations
- Sector
- HTB
- SAGE Health Care
- Exchange
- HTB NYSE
- SAGE Nasdaq
- Market Cap
- HTB 636.8M
- SAGE 571.7M
- IPO Year
- HTB N/A
- SAGE 2014
- Fundamental
- Price
- HTB $39.07
- SAGE $9.20
- Analyst Decision
- HTB Buy
- SAGE Hold
- Analyst Count
- HTB 1
- SAGE 18
- Target Price
- HTB $43.00
- SAGE $10.06
- AVG Volume (30 Days)
- HTB 55.9K
- SAGE 3.0M
- Earning Date
- HTB 07-23-2025
- SAGE 07-30-2025
- Dividend Yield
- HTB 1.23%
- SAGE N/A
- EPS Growth
- HTB N/A
- SAGE N/A
- EPS
- HTB 3.16
- SAGE N/A
- Revenue
- HTB $193,954,000.00
- SAGE $47,404,000.00
- Revenue This Year
- HTB $6.54
- SAGE $102.21
- Revenue Next Year
- HTB $1.75
- SAGE $43.01
- P/E Ratio
- HTB $12.36
- SAGE N/A
- Revenue Growth
- HTB 0.68
- SAGE N/A
- 52 Week Low
- HTB $28.53
- SAGE $4.62
- 52 Week High
- HTB $39.07
- SAGE $13.47
- Technical
- Relative Strength Index (RSI)
- HTB N/A
- SAGE 73.11
- Support Level
- HTB N/A
- SAGE $9.04
- Resistance Level
- HTB N/A
- SAGE $9.30
- Average True Range (ATR)
- HTB 0.00
- SAGE 0.15
- MACD
- HTB 0.00
- SAGE 0.03
- Stochastic Oscillator
- HTB 0.00
- SAGE 95.50
About HTB HOMETRUST BANCSHARES INC
HomeTrust Bancshares Inc operates as a bank holding company. It engaged in the business of planning, directing and coordinating the business activities of the Bank. The Bank is a North Carolina state chartered bank and provides a range of retail and commercial banking products. Company's principal business consists of attracting deposits from the general public and investing those funds, along with borrowed funds, in commercial real estate loans, construction and development loans, commercial and industrial loans, equipment finance leases, municipal leases, loans secured by first and second mortgages on one-to-four family residences including home equity loans and other consumer loans.
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.